ERGIC3 anticorps (N-Term)
Aperçu rapide pour ERGIC3 anticorps (N-Term) (ABIN2261870)
Antigène
Voir toutes ERGIC3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-30, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- ERGIC3, NT (ERGIC3, C20orf47, ERV46, SDBCAG84, Endoplasmic reticulum-Golgi intermediate compartment protein 3, Serologically defined breast cancer antigen NY-BR-84)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- ERGIC3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1~30 amino acids from the N-terminal region of human ERGIC3.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
-
Autre désignation
- ERGIC3
-
UniProt
- Q9Y282
Antigène
-